NCT00908739 Studying Tumor Tissue Samples From Patients Who Have Undergone Surgery for Localized Kidney Cancer Status WITHDRAWN Phase N/A
NCT00900536 DNA Analysis of Blood and/or Tissue Samples From Patients With Primary Kidney Cancer Receiving Sorafenib on Clinical Trial MRC-RE05-SORCE Status COMPLETED Phase N/A
NCT00900276 Biomarkers in Patients With Kidney Cancer or Cancer of the Urothelium and in Healthy Participants Status COMPLETED Phase N/A
NCT00900042 SWOG-9023, DNA Analysis of Tumor Tissue From Patients With Metastatic Kidney Cancer Status COMPLETED Phase N/A
NCT00899860 Gene Expression in Normal Tissue and Tumor Tissue From Patients Who Have Undergone Surgery For Kidney Cancer Status TERMINATED Phase N/A
NCT00896467 Psychological and Emotional Impact in Patients Undergoing Treatment For Metastatic Cancer Either in a Clinical Trial or as Standard Off-Trial Therapy Status TERMINATED Phase N/A
NCT00896454 Study of Denosumab in the Treatment of Hypercalcemia of Malignancy in Subjects With Elevated Serum Calcium Status COMPLETED Phase PHASE2
NCT00873236 MRI Scans of Blood Vessel Changes Caused by Bevacizumab Alone or Given Together With Interferon Alpha-2a in Treating Patients With Stage III or Stage IV Kidney Cancer Status UNKNOWN Phase PHASE2
NCT00866320 Sorafenib in Treating Patients With Metastatic Kidney Cancer That Has Not Responded to Sunitinib or Bevacizumab Status COMPLETED Phase PHASE2
NCT00854620 Safety and Toxicity Study of Sorafenib in Patients With Kidney Cancer Status COMPLETED Phase PHASE2
NCT00853125 Sunitinib and Irradiated Donor Lymphocytes in Treating Patients With Metastatic Kidney Cancer Status TERMINATED Phase PHASE2
NCT00853021 Bevacizumab and Aldesleukin in Treating Patients With Metastatic Clear Cell Carcinoma of the Kidney Status COMPLETED Phase PHASE2
NCT00849186 Sunitinib and Surgery in Treating Patients With Localized or Metastatic Kidney Cancer Status COMPLETED Phase NA
NCT00831480 Everolimus (RAD001) For Advanced Renal Cell Carcinoma (RCC) Before Kidney Removal Status TERMINATED Phase PHASE2
NCT00814021 Sunitinib in Treating Patients With Kidney Cancer That Has Spread to the Brain Status COMPLETED Phase PHASE2
NCT00806650 Anti-IMP3 Autoantibody and MicroRNA Signature Blood Tests in Finding Metastasis in Patients With Localized or Metastatic Kidney Cancer Status COMPLETED Phase N/A
NCT00790569 Varenicline or Nicotine Patch and Nicotine Gum in Helping Smokers in a Methadone Treatment Program Stop Smoking Status COMPLETED Phase NA
NCT00788125 Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors Status TERMINATED Phase PHASE1/PHASE2
NCT00787761 Early Administration of ATG Followed by Cyclophosphamide, Busulfan and Fludarabine Before a Donor Stem Cell Transplant in Patients With Hematological Cancer Status COMPLETED Phase PHASE2
NCT00782275 Avastin and Temsirolimus Following Tyrosine Kinase Inhibitor Failure in Patients With Advanced Renal Cell Carcinoma Status COMPLETED Phase PHASE2